KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viatris (VTRS) Other Accumulated Expenses (2019 - 2025)

Viatris (VTRS) has 5 years of Other Accumulated Expenses data on record, last reported at $3.7 billion in Q4 2024.

  • For Q4 2024, Other Accumulated Expenses rose 9.75% year-over-year to $3.7 billion; the TTM value through Dec 2024 reached $3.7 billion, up 9.75%, while the annual FY2024 figure was $3.7 billion, 9.75% up from the prior year.
  • Other Accumulated Expenses reached $3.7 billion in Q4 2024 per VTRS's latest filing, up from $3.4 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.6 billion in Q4 2021 and bottomed at $27.8 million in Q2 2020.
  • Average Other Accumulated Expenses over 5 years is $2.8 billion, with a median of $3.4 billion recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: decreased 25.52% in 2022, then rose 9.75% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $79.0 million in 2020, then soared by 5747.59% to $4.6 billion in 2021, then fell by 25.52% to $3.4 billion in 2022, then decreased by 1.37% to $3.4 billion in 2023, then increased by 9.75% to $3.7 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $3.7 billion in Q4 2024, $3.4 billion in Q4 2023, and $3.0 billion in Q2 2023.